These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Failure of a second temozolomide cycle in a patient with a prolactin-secreting pituitary carcinoma. Bilbao I; Egaña N; García C; Olaizola I Endocrinol Diabetes Nutr; 2017 Dec; 64(10):564-566. PubMed ID: 29137963 [No Abstract] [Full Text] [Related]
4. Long-term control of a MEN1 prolactin secreting pituitary carcinoma after temozolomide treatment. Philippon M; Morange I; Barrie M; Barlier A; Taieb D; Dufour H; Conte-Devolx B; Brue T; Castinetti F Ann Endocrinol (Paris); 2012 Jun; 73(3):225-9. PubMed ID: 22520146 [TBL] [Abstract][Full Text] [Related]
5. Long-course temozolomide in aggressive pituitary adenoma: real-life experience in two tertiary care centers and review of the literature. Lizzul L; Lombardi G; Barbot M; Ceccato F; Gardiman MP; Regazzo D; Bellu L; Mazza E; Losa M; Scaroni C Pituitary; 2020 Aug; 23(4):359-366. PubMed ID: 32232709 [TBL] [Abstract][Full Text] [Related]
6. Evolution of a prolactin-secreting pituitary microadenoma into a fatal carcinoma: a case report. Guastamacchia E; Triggiani V; Tafaro E; De Tommasi A; De Tommasi C; Luzzi S; Sabbà C; Resta F; Terreni MR; Losa M Minerva Endocrinol; 2007 Sep; 32(3):231-6. PubMed ID: 17912159 [TBL] [Abstract][Full Text] [Related]
7. Gangliocytoma masquerading as a prolactinoma. Case report. McCowen KC; Glickman JN; Black PM; Zervas NT; Lidov HG; Garber JR J Neurosurg; 1999 Sep; 91(3):490-5. PubMed ID: 10470826 [TBL] [Abstract][Full Text] [Related]
8. What causes a prolactinoma to be aggressive or to become a pituitary carcinoma? Phillips J; East HE; French SE; Melcescu E; Hamilton RD; Nicholas WC; Fratkin JF; Parent AD; Luzardo G; Koch CA Hormones (Athens); 2012; 11(4):477-82. PubMed ID: 23422771 [TBL] [Abstract][Full Text] [Related]
9. Case report of sarcoma of the sella caused by postoperative radiotherapy for a prolactin-producing pituitary adenoma. Kurosaki M; Kambe A; Ishibashi M; Watanabe T; Horie Y Brain Tumor Pathol; 2014 Jul; 31(3):187-91. PubMed ID: 24446079 [TBL] [Abstract][Full Text] [Related]
11. Use of temozolomide in aggressive pituitary tumors: case report. Mohammed S; Kovacs K; Mason W; Smyth H; Cusimano MD Neurosurgery; 2009 Apr; 64(4):E773-4; discussion E774. PubMed ID: 19349807 [TBL] [Abstract][Full Text] [Related]
12. Evolution of a refractory prolactin-secreting pituitary adenoma into a pituitary carcinoma: report of a challenging case and literature review. Dai C; Sun B; Guan S; Wang W; Liu H; Li Y; Zhang J; Kang J BMC Endocr Disord; 2021 Oct; 21(1):217. PubMed ID: 34715828 [TBL] [Abstract][Full Text] [Related]
13. Early Recognition and Initiation of Temozolomide Chemotherapy for Refractory, Invasive Pituitary Macroprolactinoma with Long-Term Sustained Remission. Barkhoudarian G; Palejwala SK; Ogunbameru R; Wei H; Eisenberg A; Kelly DF World Neurosurg; 2018 Oct; 118():118-124. PubMed ID: 30031177 [TBL] [Abstract][Full Text] [Related]
14. Salvage therapy with temozolomide in patients with aggressive or metastatic pituitary adenomas: experience in six cases. Losa M; Mazza E; Terreni MR; McCormack A; Gill AJ; Motta M; Cangi MG; Talarico A; Mortini P; Reni M Eur J Endocrinol; 2010 Dec; 163(6):843-51. PubMed ID: 20870708 [TBL] [Abstract][Full Text] [Related]
15. [Efficacy of total removal or subtotal removal combined gamma knife radiation on giant pituitary adenoma: a report of 160 cases]. Xiao QH; Huang SQ; Mao BY; Li GP; Ju Y Ai Zheng; 2007 Jul; 26(7):742-7. PubMed ID: 17626751 [TBL] [Abstract][Full Text] [Related]
16. Pituitary atypical adenoma or carcinoma sensitive to temozolomide combined with radiation therapy: a case report of early identification and management. Zhong C; Yin S; Zhou P; Jiang S Turk Neurosurg; 2014; 24(6):963-6. PubMed ID: 25448217 [TBL] [Abstract][Full Text] [Related]
17. Successful treatment of leptomeningeally metastasised pituitary carcinoma with temozolomide. van der Vlist A; Snijders TJ; Stades AME; Spliet WGM; De Vos FYFL Neth J Med; 2017 Dec; 75(10):451-454. PubMed ID: 29256415 [TBL] [Abstract][Full Text] [Related]
18. Rapid re-enlargement of a macroprolactinoma after initial shrinkage in a young woman treated with bromocriptine. Adler I; Barsi P; Czirják S; Varga I; Gergics P; Jakab C; Rácz K Gynecol Endocrinol; 2005 Jun; 20(6):317-21. PubMed ID: 16019380 [TBL] [Abstract][Full Text] [Related]